Suchergebnisse - "antibodies"

PubPharm (22.806)

101

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

102

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Laverdure, S. | Kazadi, D. | Kone, K. | +66

103

Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants : A Propensity Score-Matched Cohort Study

enthalten in: Infectious diseases and therapy | 2024

von Hwang, S. | Lee, N. | Nam, E. | +10

104

Serum Dehydroepiandrosterone sulfate (DHEA-S) level and its potential impact on immune responses and symptom severity after Oxford-AstraZeneca COVID-19 vaccination

enthalten in: International immunopharmacology | 2024

von Abbasifard, M. | Dehghan Banadaki, M. | Taghipour Khaje Sharifi, G. | +2

105

Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies : Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape

enthalten in: International journal of molecular sciences | 2024

von Raisinghani, N. | Alshahrani, M. | Gupta, G. | +1

106

Immunogenicity of different nanoparticle adjuvants containing recombinant RBD coronavirus antigen in animal model

enthalten in: Biotechnology and applied biochemistry | 2024

von Ataei, F. | Ahmadi, A. | Fasihi-R, M. | +3

107

Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis : a cohort study

enthalten in: Annals of the rheumatic diseases | 2024

von Schiff, A. | Wang, X. | Patel, N. | +13

UpdateOf: medRxiv. 2023 Oct 09;:. - PMID 37873462

108

Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy : A Prospective Cohort Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Hillyer, A. | Quint, A. | Ghassemian, A. | +15

109

COVID-19 vaccination in cancer patients : Immune responses one year after the third dose

enthalten in: Vaccine | 2024

von Campagna, R. | Dominelli, F. | Zingaropoli, M. | +14

110

Humoral and cellular immunity to SARS-CoV-2 following vaccination with non-mRNA vaccines in adolescent/young adults with cancer : A prospective cohort study

enthalten in: Vaccine | 2024

von Sasi, A. | Dandotiya, J. | Kaushal, J. | +9